Abstract:Idiopathic pulmonary fibrosis (IPF), the scarring of lung parenchyma resulting in the loss of lung function, remains a fatal disease with a significant unmet medical need. Patients with severe IPF often develop acute exacerbations resulting in the rapid deterioration of lung function, requiring transplantation. Understanding the pathophysiological mechanisms contributing to IPF is key to develop novel therapeutic approaches for end-stage disease.We report here RNA-sequencing analyses of lung tissues from a coh… Show more
“…Thus, changes in the expression levels of these candidate genes by p38 activity may be involved in promoting fibrosis through molecular interactions between epithelial and immune cells in the IPF lung. This hypothesis is supported by two previous reports showing an association of lymphocytes and epithelial cells with progressive fibrosis in transcriptome analysis of IPF lungs [60,61]. Therefore, the interplay between these genes and the p38 MAPK pathway may be key to understanding the immunological mechanisms underlying IPF progression.…”
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing lung disease that is caused by the dysregulation of alveolar epithelial type II cells (AEC II). The mechanisms involved in the progression of IPF remain incompletely understood, although the immune response accompanied by p38 mitogen-activated protein kinase (MAPK) activation may contribute to some of them. This study aimed to examine the association of p38 activity in the lungs with bleomycin (BLM)-induced pulmonary fibrosis and its transcriptomic profiling. Accordingly, we evaluated BLM-induced pulmonary fibrosis during an active fibrosis phase in three genotypes of mice carrying stepwise variations in intrinsic p38 activity in the AEC II and performed RNA sequencing of their lungs. Stepwise elevation of p38 signaling in the lungs of the three genotypes was correlated with increased severity of BLM-induced pulmonary fibrosis exhibiting reduced static compliance and higher collagen content. Transcriptome analysis of these lung samples also showed that the enhanced p38 signaling in the lungs was associated with increased transcription of the genes driving the p38 MAPK pathway and differentially expressed genes elicited by BLM, including those related to fibrosis as well as the immune system. Our findings underscore the significance of p38 MAPK in the progression of pulmonary fibrosis.
“…Thus, changes in the expression levels of these candidate genes by p38 activity may be involved in promoting fibrosis through molecular interactions between epithelial and immune cells in the IPF lung. This hypothesis is supported by two previous reports showing an association of lymphocytes and epithelial cells with progressive fibrosis in transcriptome analysis of IPF lungs [60,61]. Therefore, the interplay between these genes and the p38 MAPK pathway may be key to understanding the immunological mechanisms underlying IPF progression.…”
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing lung disease that is caused by the dysregulation of alveolar epithelial type II cells (AEC II). The mechanisms involved in the progression of IPF remain incompletely understood, although the immune response accompanied by p38 mitogen-activated protein kinase (MAPK) activation may contribute to some of them. This study aimed to examine the association of p38 activity in the lungs with bleomycin (BLM)-induced pulmonary fibrosis and its transcriptomic profiling. Accordingly, we evaluated BLM-induced pulmonary fibrosis during an active fibrosis phase in three genotypes of mice carrying stepwise variations in intrinsic p38 activity in the AEC II and performed RNA sequencing of their lungs. Stepwise elevation of p38 signaling in the lungs of the three genotypes was correlated with increased severity of BLM-induced pulmonary fibrosis exhibiting reduced static compliance and higher collagen content. Transcriptome analysis of these lung samples also showed that the enhanced p38 signaling in the lungs was associated with increased transcription of the genes driving the p38 MAPK pathway and differentially expressed genes elicited by BLM, including those related to fibrosis as well as the immune system. Our findings underscore the significance of p38 MAPK in the progression of pulmonary fibrosis.
“…Notably, MEOX1 expression was significantly up-regulated in human diseases that prominently feature fibrosis, such as heart tissue from patients with cardiomyopathy and lung tissue from patients with idiopathic pulmonary fibrosis (Fig. 4H,I) 30 .…”
Section: Introductionmentioning
confidence: 99%
“…2H and Extended data Fig. 4A), a homeodomain-containing TF that is expressed in paraxial mesoderm and is required for sclerotome development 29,30 . Meox1 was particularly interesting because it was minimally expressed in the healthy mouse heart but highly upregulated in MyoFBs following TAC ( Fig.…”
In diseased organs, stress-activated signaling cascades alter chromatin, triggering broad shifts in transcription and cell state that exacerbate pathology. Fibroblast activation is a common stress response that worsens lung, liver, kidney and heart disease, yet its mechanistic basis remains poorly understood1,2. Pharmacologic inhibition of the BET family of transcriptional coactivators alleviates cardiac dysfunction and associated fibrosis, providing a tool to mechanistically interrogate maladaptive fibroblast states and modulate their plasticity as a potential therapeutic approach3–8. Here, we leverage dynamic single cell transcriptomic and epigenomic interrogation of heart tissue with and without BET inhibition to reveal a reversible transcriptional switch underlying stress-induced fibroblast activation. Transcriptomes of resident cardiac fibroblasts demonstrated robust and rapid toggling between the quiescent fibroblast and activated myofibroblast state in a manner that directly correlated with BET inhibitor exposure and cardiac function. Correlation of single cell chromatin accessibility with cardiac function revealed a novel set of reversibly accessible DNA elements that correlated with disease severity. Among the most dynamic elements was an enhancer regulating the transcription factor MEOX1, which was specifically expressed in activated myofibroblasts, occupied putative regulatory elements of a broad fibrotic gene program, and was required for TGFβ-induced myofibroblast activation. CRISPR interference of the most dynamic cis-element within the enhancer, marked by nascent transcription, prevented TGFβ-induced activation of Meox1. These findings identify MEOX1 as a central regulator of stress-induced myofibroblast activation associated with cardiac dysfunction. The plasticity and specificity of the BET-dependent regulation of MEOX1 in endogenous tissue fibroblasts provides new trans- and cis- targets for treating fibrotic disease.
“…It is important to note that ECs were experimentally generated using a specific cell culture method and that their in vivo relevance is yet to be determined. Overlapping findings with the GSE134692 dataset based on primary tissue specimens from lung transplant recipients and donors [16] suggest, however, that our model may be able to capture the principal signatures of the IPFaffected lung including upregulation of CXCL8, LIF, and PTGS2. CXLC8 (encoding interleukin 8) is an inflammatory mediator attracting neutrophils and contributing to pathogen clearance, but may also confer secondary fibrotic tissue damage [18,19].…”
Section: Discussionmentioning
confidence: 95%
“…As shown in Supplementary Figure 1A, four out of five key genes (CXCL8, ICAM1, LIF, PTGS2) could be validated as overexpressed in IPF, with the remaining gene (IL7R) showing enrichment in IPF samples as well without reaching statistical significance. Moreover, comparing these key genes to the publically available GSE134692 dataset [16], we found that three of the genes (CXCL8, LIF, PTGS2) showed the same direction of regulation among IPF and non-IPF samples, whereas ICAM1 and IL7R were differentially regulated between the datasets ( Supplementary Figure 1B). This suggested both similarities and characteristic differences between the datasets, thus corroborating our findings but also highlighting the distinct nature of our ex vivo model in comparison to primary explanted tissue.…”
Section: Principal Signatures Of Ecs From An Ipf Sourcementioning
Background: Idiopathic pulmonary fibrosis (IPF) is an incurable disease characterized by progressive lung fibrosis ultimately resulting in respiratory failure and death. Recurrent micro-injuries to the alveolar epithelium and aberrant alveolar wound healing with impaired re-epithelialization define the initial steps of the pathogenic trajectory. Failure of timely alveolar epithelial repair triggers hyper-proliferation of mesenchymal cells accompanied by increased deposition of extracellular matrix into the lung interstitium. Methods: We previously isolated fibrosis-specific mesenchymal stem cell (MSC)-like cells from lung tissue of patients with interstitial lung diseases. These cells produced factors bearing anti-fibrotic potential and changed their morphology from mesenchymal to epithelial upon culture in an epithelial cell (EC)-specific growth medium. Here, we set out to molecularly characterize these MSC-like cell-derived ECs using global gene expression profiling by RNA-sequencing. Moreover, we aimed at characterizing disease-specific differences by comparing the transcriptomes of ECs from IPF and non-IPF sources. Results: Our results suggest that differentially expressed genes are enriched for factors related to fibrosis, hypoxia, bacterial colonization and metabolism, thus reflecting many of the hallmark characteristics of pulmonary fibrosis. IPF-ECs showed enrichment of both pro-and anti-fibrotic genes, consistent with the notion of adaptive, compensatory regulation. Conclusions: Our findings support the hypothesis of a functional impairment of IPF-ECs, which could possibly explain the poor clinical outcome of IPF that roughly compares to those of advanced-stage cancers. Our study provides a valuable resource for downstream mechanistic investigation and the quest for novel therapeutic IPF targets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.